Large Pharmaceuticals
Market Cap
₹1,14,311 Cr.
P/E
21.44
  • Lupin
  • Zydus Lifesciences
  • Cipla
  • TJI Pharma

FAQs on Lupin Ltd. Shareprice

Lupin has given better returns compared to its competitors.
Lupin has grown at ~38.86% over the last 3yrs while peers have grown at a median rate of 15.51%

Lupin is not expensive.
Latest PE of Lupin is 21.44, while 3 year average PE is 56.69.
Also latest EV/EBITDA of Lupin is 13.0 while 3yr average is 30.01.

Growth Table

  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Balance Sheet

  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Cash Flow

  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Quarterly Results

  • Lupin Ltd.
  • Zydus Lifesciences
  • Cipla

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Lupin Ltd. Financials

Balance sheet of Lupin is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Lupin is decreasing.
Latest net debt of Lupin is -₹5,379.13 Crs as of Mar-26.
This is less than Mar-25 when it was -₹1,185.51 Crs.

Yes, profit is increasing.
The profit of Lupin is ₹5,333 Crs for Mar 2026, ₹3,282 Crs for Mar 2025 and ₹1,914 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lupin latest dividend payout ratio is 15.43% and 3yr average dividend payout ratio is 17.06%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech